Skip to main content
. Author manuscript; available in PMC: 2014 Apr 21.
Published in final edited form as: J Allergy Clin Immunol. 2008 Jun 24;122(2):335–341.e3. doi: 10.1016/j.jaci.2008.05.020

TABLE II. Airway structural changes in asthma and EB.

Asthma (n = 42)
Control (n = 19) Eosinophilic bronchitis (n = 21) GINA 1 (n = 17) GINA 2-4 (n = 15) Refractory (n = 10)
RBM thickness (μm) 6.6 (0.4) 11.1 (0.96) 9.5 (0.77) 8.9 (1.1) 11.0 (0.7)*
Percent ASM 8.5 (1.3) 17.9 (3.4) 17.2 (1.9) 16.1 (3.6) 16.3 (2.8)*
Percent glands 1.6 (0.61) 3.1 (1.4) 0.82 (0.3) 2.4 (1.5) 4.9 (1.6)
Percent collagen 3 lamina propria 8.9 (2.3) 7.4 (2.1) 2.6 (1.3) 1.4 (0.4) 6.9 (2.3)*
Collagen 3 SQS lamina propria 2.02 (0.2) 2.36 (0.15) 1.85 (0.27) 1.68 (0.16)§ 2.23 (0.30)
Collagen 3 SQS ASM (mean score) 0.56 (0.1) 0.68 (0.08) 0.58 (0.14) 0.43 (0.11) 0.68 (0.13)
Collagen 3 SQS ASM (number positive) 7/18 6/14 5/10 7/15 7/10
Mast cells/mm2 ASM 3.1 (0.63) 1.03 (0.41) 8.8 (2.3)§ 11.7 (2.3)§ 15.6 (2.6)*§

SQS, Semiquantitative score.

Data expressed as means (SEMs).

*

P < .05 1-way ANOVA; normal vs EB/GINA 1, GINA 2-4, refractory asthma.

P < .05 vs control (Mann-Whitney tests/t tests for intergroup comparisons).

P < .05 vs GINA 2-4 asthma (Mann-Whitney tests/t tests for intergroup comparisons).

§

P < .05 vs EB (Mann-Whitney tests/t tests for intergroup comparisons).

HHS Vulnerability Disclosure